Soc. Generale Knock-Out GM/ DE000SU7QTZ1 /
03/06/2024 16:35:29 | Var.+0.070 | Denaro17:33:40 | Lettera17:33:40 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.830EUR | +9.21% | 0.820 Quantità in denaro: 200,000 |
0.830 Quantità in lettera: 200,000 |
General Motors Compa... | 36.5756 USD | 31/12/2078 | Call |
GlobeNewswire
17:35
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire
17:33
Natiivo Hospitality Expands with New South Florida Projects, Hires Yoav Gery as President
GlobeNewswire
17:30
Titan.ium Platform Announces Collaboration with Nokia Improving Security for Global Telecommunicatio...
GlobeNewswire
17:20
New CryptoStaking Strategies Introduced by CryptoHeap to Maximize Investor Returns
GlobeNewswire
17:15
DEADLINE ALERT for HRT and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions...
GlobeNewswire
17:13
Los Angeles Student Wins NFTE West (Southern California) Youth Entrepreneurship Challenge
GlobeNewswire
17:12
Kirby McInerney LLP Reminds Harbor Diversified, Inc. (HRBR) Investors of Class Action Filing and Enc...
GlobeNewswire
17:11
Kirby McInerney LLP Reminds Global Cord Blood Corporation (CORBF) Investors of Upcoming Deadline in ...
GlobeNewswire
17:11
Infuse Summer Fun In Your Coffee With Bones Coffee Company’s New, Limited-Edition Summer Flavors
GlobeNewswire
17:02
Cambria Investment Management and Chesapeake Capital Corporation Announces the Launch of the Cambria...
GlobeNewswire
17:00
MidWestOne Financial Group Welcomes Three Key Executive Leaders to the Organization
GlobeNewswire
17:00
Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopa...
GlobeNewswire
17:00
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...